Latest NEXI reports update at 2024-04-16: 20232022
NexImmune logo
NexImmune NEXI
$ 3.46 2.37%

NexImmune Financial Statements 2011-2024 | NEXI

Annual Financial Statements NexImmune

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

3.64 M 366 K 64 M - - - - - - - - - -

Shares

1.05 M 962 K 20.2 M - - - - - - - - - -

Historical Prices

3.47 0.38 3.17 - - - - - - - - - -

Net Income

-32.3 M -62.5 M -50.9 M -29.9 M -20.5 M -12.8 M - - - - - - -

Revenue

- - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - -

Operating Income

-33 M -63.1 M -53.3 M -27.9 M - - - - - - - - -

Interest Expense

-69.2 K -87.7 K 905 K 1.68 M - - - - - - - - -

EBITDA

-31.9 M -62.1 M -52.4 M - -20.4 M -13 M - - - - - - -

Operating Expenses

33 M 63.1 M 53.3 M 27.9 M - - - - - - - - -

General and Administrative Expenses

13 M 15.9 M 15.8 M 10 M 5.71 M 5.24 M - - - - - - -

All numbers in USD currency

Quarterly Income Statement NexImmune

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

1.05 M 26.1 M 26.1 M 1.04 M 976 K 22.9 M 22.8 M 22.8 M 22.7 M 22.6 M 12.6 M 1.26 M 1.25 M 1.25 M 1.25 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-9.85 M -7.57 M -9.57 M - -14.7 M -15.9 M -15 M - -14.6 M -12.2 M -8.55 M - -8.61 M -6.93 M -6.32 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-10 M -7.78 M -9.83 M - -14.9 M -15.9 M -15.1 M - -15.5 M -12.2 M -10.1 M - -7.67 M -6.77 M -6.36 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

-13.3 K -5.17 K -14.4 K - -100 K -19 K -2.58 K - 1.11 K 101 904 K - 559 K 184 K 989 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

- - -9.56 M - -14.1 M -15.5 M -14.8 M - -14.9 M -11.8 M -9.9 M - -7.22 M -6.48 M -6.22 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

10 M 7.78 M 9.83 M - 14.9 M 15.9 M 15.1 M - 15.5 M 12.2 M 10.1 M - 7.67 M 6.77 M 6.36 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

3.99 M 2.9 M 3.7 M - 3.72 M 4.09 M 4.6 M - 4.16 M 4.04 M 4.06 M - 2.75 M 2.57 M 2.09 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency